A detailed history of Vanguard Group Inc transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 905,387 shares of PLSE stock, worth $13.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
905,387
Previous 847,212 6.87%
Holding current value
$13.2 Million
Previous $7.38 Million 37.3%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$6.69 - $14.54 $389,190 - $845,864
58,175 Added 6.87%
905,387 $10.1 Million
Q1 2024

May 10, 2024

BUY
$7.8 - $11.02 $1.48 Million - $2.09 Million
189,227 Added 28.76%
847,212 $7.38 Million
Q4 2023

Feb 14, 2024

BUY
$3.85 - $12.84 $1.22 Million - $4.06 Million
316,519 Added 92.69%
657,985 $8.05 Million
Q3 2023

Nov 14, 2023

BUY
$4.03 - $8.73 $207,085 - $448,599
51,386 Added 17.71%
341,466 $1.38 Million
Q2 2023

Aug 14, 2023

SELL
$3.67 - $8.64 $1.02 Million - $2.41 Million
-278,555 Reduced 48.99%
290,080 $2.09 Million
Q1 2023

May 15, 2023

BUY
$2.48 - $3.88 $9,575 - $14,980
3,861 Added 0.68%
568,635 $1.91 Million
Q4 2022

Feb 10, 2023

BUY
$1.73 - $2.89 $520 - $869
301 Added 0.05%
564,774 $1.56 Million
Q3 2022

Nov 14, 2022

SELL
$1.23 - $2.3 $29,877 - $55,869
-24,291 Reduced 4.13%
564,473 $1.3 Million
Q2 2022

Aug 12, 2022

SELL
$1.48 - $4.28 $107,529 - $310,963
-72,655 Reduced 10.98%
588,764 $901,000
Q1 2022

May 13, 2022

SELL
$4.21 - $14.79 $15,252 - $53,584
-3,623 Reduced 0.54%
661,419 $3.21 Million
Q4 2021

Feb 14, 2022

SELL
$14.78 - $24.4 $662,336 - $1.09 Million
-44,813 Reduced 6.31%
665,042 $9.85 Million
Q3 2021

Nov 12, 2021

BUY
$17.25 - $26.63 $110,520 - $170,618
6,407 Added 0.91%
709,855 $15.3 Million
Q2 2021

Aug 13, 2021

BUY
$16.31 - $23.64 $11.5 Million - $16.6 Million
703,448 New
703,448 $11.5 Million

Others Institutions Holding PLSE

About Pulse Biosciences, Inc.


  • Ticker PLSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,125,900
  • Market Cap $541M
  • Description
  • Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...
More about PLSE
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.